Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederema.europa.eu
What's new
Get the latest updates from What's new directly as they happen.
Follow now 332 followers
Latest posts
Last updated 34 minutes ago
Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Date of authorisation: 26/08/2013, Revision: 21, Status: Authorised
41 minutes ago
Human medicines European public assessment report (EPAR): Nexium Control, esomeprazole, Date of...
EMA’s API general terms and conditions of use - Terms of use
about 1 hour ago
EMA’s API general terms and conditions of use - Terms of use
Updates to industry contact management for authorisation products (IRIS), Online, European Medicines Agency, Amsterdam, the Netherlands, from 11 June 2026, 11:00 (CEST) to 11 June 2026, 12:15 (CEST)
about 2 hours ago
Updates to industry contact management for authorisation products (IRIS), Online, European Medicines...
Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures European Commission final decision, 26/03/2026, 29/05/2026, 02/06/2026
about 20 hours ago
Referral: Tecovirimat SIGA, tecovirimat Article 20 procedures European Commission final decision, 26/03/2026...
Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date of authorisation: 22/11/2024, Revision: 2, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Theralugand, lutetium (177Lu) chloride, Date...
Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation: 19/11/2015, Revision: 39, Status: Authorised
about 20 hours ago
Human medicines European public assessment report (EPAR): Orkambi, lumacaftor,ivacaftor, Date of authorisation...
Questions and answers on the refusal of a change to the marketing authorisation for Hetlioz (tasimelteon) (II-40)
about 20 hours ago
Questions and answers on the refusal of a change to the marketing...
Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, Date of authorisation: 06/05/2019, Revision: 11, Status: Authorised
about 21 hours ago
Human medicines European public assessment report (EPAR): Pazenir, paclitaxel, Date of authorisation...
Human medicines European public assessment report (EPAR): Zandoriah, teriparatide, Date of authorisation: 27/04/2026, Status: Authorised
about 22 hours ago
Human medicines European public assessment report (EPAR): Zandoriah, teriparatide, Date of authorisation...
Policy 84: Multilingualism on the EMA website and in external communications
about 23 hours ago
Policy 84: Multilingualism on the EMA website and in external communications